affiliation not provided to SSRN
Ciprofloxacin-hybrids, Peptidomimetics, Passerini reaction, Anticancer activity, Chemosensitization activity, P-glycoprotein interactions, in vitro toxicity
Cisplatin resistance, ruthenium-cyclopentadienyl, non-small cell lung